These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32884532)

  • 21. Recombinant human thrombopoietin treatment in patients with chronic liver disease-related thrombocytopenia undergoing invasive procedures: A retrospective study.
    Ding JN; Feng TT; Sun W; Cai XY; Zhang Y; Zhao WF
    World J Gastrointest Surg; 2022 Nov; 14(11):1260-1271. PubMed ID: 36504518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dental procedures in 24 patients with chronic immune thrombocytopenia in prospective clinical studies of eltrombopag.
    Tarantino MD; Fogarty PF; Shah P; Brainsky A
    Platelets; 2015; 26(1):93-6. PubMed ID: 24433306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidine.
    Svensson T; Chowdhury O; Garelius H; Lorenz F; Saft L; Jacobsen SE; Hellström-Lindberg E; Cherif H
    Eur J Haematol; 2014 Nov; 93(5):439-45. PubMed ID: 24853277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trial.
    Mittelman M; Platzbecker U; Afanasyev B; Grosicki S; Wong RSM; Anagnostopoulos A; Brenner B; Denzlinger C; Rossi G; Nagler A; Garcia-Delgado R; Portella MSO; Zhu Z; Selleslag D
    Lancet Haematol; 2018 Jan; 5(1):e34-e43. PubMed ID: 29241762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current Advance in Thrombopoietin Receptor Agonists in the Management of Thrombocytopenia Associated With Chronic Liver Disease: Focus on Avatrombopag.
    Abdela J
    Clin Med Insights Blood Disord; 2019; 12():1179545X19875105. PubMed ID: 31673229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Portal vein thrombosis as complication of romiplostim treatment in a cirrhotic patient with hepatitis C-associated immune thrombocytopenic purpura.
    Dultz G; Kronenberger B; Azizi A; Mihm U; Vogl TJ; Sarrazin U; Sarrazin C; Zeuzem S; Hofmann WP
    J Hepatol; 2011 Jul; 55(1):229-32. PubMed ID: 21310200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebral Venous Thrombosis in a Patient with Immune Thrombocytopenia, an Apparent Paradox.
    Rasheed MA; Alsaud AE; Razzaq S; Fadul A; Yassin MA
    Case Rep Oncol; 2020; 13(2):588-594. PubMed ID: 32595467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eltrombopag-related renal vein thromboembolism in a patient with immune thrombocytopenia: A case report.
    Wu C; Zhou XM; Liu XD
    World J Clin Cases; 2021 Apr; 9(11):2611-2618. PubMed ID: 33889627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eltrombopag: a novel oral thrombopoietin receptor agonist.
    Corman SL; Mohammad RA
    Ann Pharmacother; 2010 Jun; 44(6):1072-9. PubMed ID: 20460556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease.
    Khemichian S; Terrault NA
    Semin Thromb Hemost; 2020 Sep; 46(6):682-692. PubMed ID: 32820479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of romiplostim in a hemodialysis patient with primary immune thrombocytopenia.
    Al-Jafar H; Giagounidis A; El-Rashaid K; Al-Ali M; Hakim AA
    Ann Pharmacother; 2012 Nov; 46(11):e31. PubMed ID: 23115229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multicentre, randomised phase III study of the efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia.
    Yang R; Li J; Jin J; Huang M; Yu Z; Xu X; Zhang X; Hou M
    Br J Haematol; 2017 Jan; 176(1):101-110. PubMed ID: 27734464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Avatrombopag for the treatment of immune thrombocytopenia and thrombocytopenia of chronic liver disease.
    Cheloff AZ; Al-Samkari H
    J Blood Med; 2019; 10():313-321. PubMed ID: 31565009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment with eltrombopag of severe immune thrombocytopenia and hemolytic anemia associated with COVID-19 pneumonia: a case report.
    Gruden G; Beggiato E; Camerino E; Capriotti S; Canepa S; Scandella M; Avolio M; Pittalunga F; Barutta F; Durazzo M
    Ther Adv Hematol; 2021; 12():20406207211011353. PubMed ID: 33995989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost effectiveness of romiplostim for the treatment of chronic immune thrombocytopenia in Ireland.
    Lee D; Thornton P; Hirst A; Kutikova L; Deuson R; Brereton N
    Appl Health Econ Health Policy; 2013 Oct; 11(5):457-69. PubMed ID: 23857462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eltrombopag: an update on the novel, non-peptide thrombopoietin receptor agonist for the treatment of immune thrombocytopenia.
    Kühne T; Imbach P
    Ann Hematol; 2010 Jul; 89 Suppl 1():67-74. PubMed ID: 20405290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population pharmacokinetic/pharmacodynamic modelling of eltrombopag in healthy volunteers and subjects with chronic liver disease.
    Farrell C; Hayes SC; Wire M; Zhang J
    Br J Clin Pharmacol; 2014 Mar; 77(3):532-44. PubMed ID: 24117976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombocytopenia associated with chronic liver disease.
    Afdhal N; McHutchison J; Brown R; Jacobson I; Manns M; Poordad F; Weksler B; Esteban R
    J Hepatol; 2008 Jun; 48(6):1000-7. PubMed ID: 18433919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eltrombopag Improves Refractory Thrombocytopenia in a Patient with Systemic Lupus Erythematosus.
    Shima N; Sumida K; Kawada M; Sekine A; Yamanouchi M; Hiramatsu R; Hayami N; Hasegawa E; Suwabe T; Hoshino J; Sawa N; Takaichi K; Ohashi K; Fujii T; Ubara Y
    Case Rep Rheumatol; 2018; 2018():6305356. PubMed ID: 30186656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eltrombopag for Post-Transplantation Thrombocytopenia: Results of Phase II Randomized, Double-Blind, Placebo-Controlled Trial.
    Ahmed S; Bashir Q; Bassett R; Poon MC; Valdez B; Konoplev S; Alousi AM; Andersson BS; Ciurea S; Hosing C; Jones R; Kebriaei P; Khouri I; Kim S; Nieto Y; Olson A; Oran B; Parmar S; Qazilbash MH; Rezvani K; Shah N; Shpall EJ; Champlin R; Popat U
    Transplant Cell Ther; 2021 May; 27(5):430.e1-430.e7. PubMed ID: 33965187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.